This weeks American Alchemist is Josh Wolfe. Josh co-founded Lux Capital to support scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time in order to lead us into a brighter future. The more ambitious the project, the better—like, say, creating matter from light.

Josh is a Director at Shapeways, Strateos, Lux Research, Kallyope, CTRL-labs, Variant, and Varda, and helped lead the firm’s investments in Anduril, Planet, Echodyne, Clarifai, Authorea, Resilience and Hadrian. He is a founding investor and board member with Bill Gates in Kymeta, making cutting-edge antennas for high-speed global satellite and space communications. Josh is a Westinghouse semi-finalist and published scientist. He previously worked in investment banking at Salomon Smith Barney and in capital markets at Merrill Lynch. In 2008 Josh co-founded and funded Kurion, a contrarian bet in the unlikely business of using advanced robotics and state-of-the-art engineering and chemistry to clean up nuclear waste. It was an unmet, inevitable need with no solution in sight. The company was among the first responders to the Fukushima Daiichi disaster. In February 2016, Veolia acquired Kurion for nearly $400 million—34 times Lux’s total investment.

*** AMERICAN ALCHEMY is an original series hosted by Jesse Michels that explores the frontier of science and tech. Each week, we bring you exclusive interviews with some of the leading thinkers of our time.

INSTAGRAM ➤ https://www.instagram.com/jessemichels

TWITTER ➤ https://twitter.com/AlchemyAmerican

EMAIL/BOOKINGS ➤ [email protected]

SUBSCRIBE TO OUR CHANNEL: https://www.youtube.com/channel/UC7eOJzNRWY4l2UTDvIquxYg?app=desktop original music: https://open.spotify.com/artist/6LlLRudDi60Uy4jcmOSEs1

-

Learn more about your ad choices. Visit megaphone.fm/adchoices